About This Source - CGTN
This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.
Recent from CGTN:
CGTN published this video item, entitled “Expert: Interim clinical trials show effective results for easier-to-produce vaccine” – below is their description.
Experts say the recombinant protein vaccine has already passed mid-stage clinical trials. CGTN’s You Yang recently caught up with Gao Fu, head of China’s Center for Disease Control and Prevention, and a researcher in microbiology at the Chinese Academy of Sciences, to get the latest on the vaccine’s development.CGTN YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: China
7 Recent Items: China
In This Story: Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.